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Sarcolipin (SLN) is a low-m olecular-weight protein  
th a t copurifies with the fast-tw itch skeletal muscle 
sarcoplasm ic reticulum Ca2+ ATPase (SERCA1). Geno­
m ic DNA and cDNA encoding hum an sarcolipin (SLN) 
w ere isolated and characterized and the SLN  gene was 
m apped to chromosome Ilq 22-q 23 . Human, rabbit, 
an d  mouse cDNAs encode a protein of 31 amino acids. 
H om ology of SLN with phospholam ban (PLN) suggests 
th a t the first 7 hydrophilic amino acids are cyto­
plasm ic, the next 19 hydrophobic amino acids form a 
sin g le  transmembrane helix , and the last 5 hydrophilic 
am ino acids are lumenal. The cytoplasm ic and trans­
m em brane sequences are not w ell conserved among 
th e  three species, but the lum enal sequence is highly  
conserved. Like SERCA1, SLN is highly expressed in  
rabbit fast-twitch skeletal m uscle, but it is expressed  
to  a lower extent in  slow-twitch m uscle and to an even  
low er extent in cardiac m uscle, where SERCA2 a and 
PLN  are highly expressed. It is expressed in only trace 
am ounts in pancreas and prostate. SLN and PLN  genes 
resem ble each other in having two small exons, w ith  
th e ir  entire coding sequences lying in exon 2  and a 
large  intron separating the tw o segm ents. Brody dis-
Sequence data from this article have been deposited with the Gen- 
13 ank/EMBL Data Libraries under Accession Nos. U96091, rabbit 
cDNA; U96092, U96093, human gDNA; U96094, human cDNA.
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ease is an inherited  disorder of skeletal m uscle func­
tion, characterized by exercise-induced im pairm ent of 
m uscle relaxation. M utations in the ATP2A1 gene en­
coding SERCA1 have been associated w ith  the autoso­
mal recessive inheritance of Brody disease in  three  
fam ilies, but not with autosomal dom inant inheritance  
of the disease. A search for m utations in  the SLN  gene  
in five Brody families, four of w hich w ere not linked  
to ATP2A1y did not reveal any alterations in  coding, 
splice junction or promoter sequences. The hom ozy­
gous deletion of C438 in  the coding sequence of 
ATP2A1 in  Brody disease family 3, leading to a 
fram eshift and truncation follow ing Pro 147 in SERCA1, 
is the fourth ATP2A1 m utation to be associated w ith
autOSOmal recessive Brody disease. © 1997 Academic Press
INTRODUCTION
Sarcolipin
Sarcolipin (SLN) was first isolated as a low-molecu- 
lar-weight proteolipid from rabbit fast-twitch skeletal 
muscle sarcoplasmic reticulum and from preparations 
of the Ca2+ ATPase (SERCA1) purified from that source 
(MacLennan et cil, 1972). Attempts were made to dis­
cover a function for SLN, by reconstitution of the pro­
teolipid with purified preparations of SERCA1 and 
measurement of any alteration in SERCA1 function.
0888-7543/97 $25.00 
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SLN was reported to enhance the coupling ratio be­
tw een Ca2+ uptake and Ca2+-dependent ATP hydroly­
sis when reconstituted with SERCA1, but, w hen puri­
fied SLN was added to the exterior of these reconstitu­
ted  liposomes, Ca2+ accumulation w as diminished, 
implying th a t  SLN m ight act as a Ca2+ ionophore 
(Racker and  Eytan, 1975). M acLennan et a l  (1980) 
fractionated SLN away from SERCA1, reconstituted 
the highly purified SERCA1 in lipid bilayers, and found 
no alteration in Ca2VATP coupling ratios before and 
after removal of SLN. Later studies by M aruyam a and 
M acLennan (1988) showed th a t  SERCA1 cDNA, ex­
pressed alone in heterologous cell culture, yielded m i­
crosomal m em branes containing fully functional Ca2+ 
uptake and Ca2+-dependent ATPase activities, sug­
gesting th a t  SLN plays no essential role in  Ca2+ up ­
take. The protein was sequenced by Wawrzynow et al. 
(1992) and named sarcolipin.
In  studies of the  yeast H + ATPase, N avarre et al. 
(1992) discovered th a t two low-molecular-weight pro- 
teolipids are associated with this P-type ATPase, In 
double m utants, lacking both proteolipids, the  Vmax of 
the H + ATPase was reduced to 50% of th a t  of wild 
type strains (Navarre et al., 1994). The m echanism  of 
interaction of these proteolipids with the  H + ATPase 
has not been determined.
Phospholamban (PLN) is a 52-amino-acid protein lo­
cated in th e  sarcoplasmic reticulum  of cardiac, slow- 
twitch, and smooth muscles, where it acts as an  inhibi­
tor of SERCA2 by lowering its  apparent affinity for 
Ca2+ (Tada and Katz, 1982). The protein has a  hydro­
philic N-terminal sequence of 30 amino acids, which 
would alter its solubility by comparison w ith  low-mo­
lecular-weight proteolipids, but, in respect to its in te r­
action w ith a P-type cation pump, it resembles other 
proteolipids.
In  this paper, we characterize the sarcolipin (S L N ) 
gene and demonstrate structural sim ilarities between 
the  SLN  and  P L N  genes, as well as homology between 
the  peptide sequences of their products. S L N  gene t r a n ­
scription is shown to be high in fast-twitch skeletal 
muscle, where SERCA1 expression predominates. By 
contrast, P L N  gene transcription was shown earlier to 
be high in  cardiac muscle, where SERCA2a expression 
predominates (Fujii et al., 1988).
Brody Disease
Brody disease is an inherited disorder of skeletal 
muscle function, characterized by exercise-induced im ­
pairm ent of muscle relaxation. Studies of the  sarcoplas­
mic reticulum  from Brody patients have shown de­
creased Ca2* uptake and Ca2+~dependent ATP hydroly­
sis, (Brody, 1969; K arpati et al., 1986: Danon et al., 
1988; Taylor et al., 1988; Wevers et al.} 1992; Poels et 
al., 1993; Benders et al., 1994). In  the studies of K arpati 
et al. (1986), no immunologically reactive ATPase was 
observed in fast-twitch fibers of probands from two
Brody families. In  la te r  studies, Benders et al. (1994) 
were unable to m easure a decrease in  SERCA1 protein 
content in  skeletal muscle from  seven Brody families, 
b u t SERCA1 activity was reduced by 50%.
We have reported the association of some cases of 
Brody disease with the autosom al recessive inheritance 
of m utations in the ATP2A1  gene, encoding SERCA1, 
in two Brody families (O derm att et al., 1996), but 
ATP2A1  was ruled out as a  candidate gene in three 
other Brody families in an earlier study  (Zhang et al,, 
1995), dem onstrating th a t  th e  cause of the disease is 
heterogeneous. Some of the non-ATP2A1-linked fami­
lies were characterized by dom inant inheritance of the 
disease. Since SERCA1 content was reported to be nor­
mal, bu t w ith reduced activity in  seven Brody patients 
studied by Benders et al. (1994), we deduced that a 
candidate gene for Brody disease m ight encode a pro­
te in  th a t  would in terac t w ith  SERCA1 and, when mu­
tated, become a dom inant inhibitor of SERCA1 func­
tion. Accordingly, the h u m an  S L N  gene was evaluated 
as a candidate gene for Brody disease. Unfortunately, 
we were unable to find any a ltera tions in coding, splice 
junction, or prom oter sequences th a t  would support 
S L N  as a candidate gene for Brody disease in five pa­
tients.
MATERIALS AND METHODS
Preparation o fR N A  and RT-PCR. Total RNA was isolated from 
norm al hum an  skeletal muscle u sin g  guanid ium -iso th iocyanate- 
phenol-chloroform  extraction (Chomczynski and  Sacchi, 1987). A 5- 
//g aliquot of to tal RNA w as reverse transcribed  in 50 fA of a reaction 
m ix (S tratagene cDNA synthesis k it) containing 50 U of MMuLV 
reverse transcrip tase  a t 37°C in th e  presence of RNase Block Inhibi­
to r and 0.5 pg  of random  prim ers. Following first-strand cDNA syn­
thesis, RNA was hydrolyzed by th e  addition of 50 (A of 0.3 N  sodium 
hydroxide and 30 m M  EDTA and  boiling for 5 min. The pH was then 
neutralized  w ith 25 fA of T ris -H C l, pH 8.3. After extraction with 
phenol and chloroform, the  cDNA w as precip ita ted  with ethanol and 
w ashed, and the pellet was dissolved in  30 pi of HaO. Aliquots of 1 
p\ of first-strand  cDNA w ere used  as the  tem plate  in subsequent 
PCR amplifications.
PCR cloning o f  partial S L N  cD NA based on known peptide se­
quence. Reverse transla tion  of th e  am ino acid sequence of rabbit 
sarcolipin (Wawrzynow et al., 1992) perm itted  the synthesis of two 
fully degenerate oligonucleotide p rim ers, SALF7 and SALR7 (Table 
1), based on the 5' and  3 ' ends of th e  cDNA coding sequence. The 
oligonucleotide prim ers also contained  nine nucleotide BamHI re ­
striction endonuclease sites a t  th e ir  5 ' ends to facilitate subsequent 
cloning of PCR products. PCR amplification w ith  primers SALF7 and 
SALR7 w as carried out using e ith e r  100 ng  of DNA from a full- 
length  rab b it skeletal muscle cDNA lib rary  (MacLennan et al., 1985) 
constructed in the  pcDX vector (O kayam a and  Berg, 1983) or, a lter­
natively, using 1 pi of firs t-s trand  cDNA derived from normal hum an 
skeletal muscle as a tem plate. Taq  polym erase and Taq Extender 
(S tratagene) were used for PCR am plification in  the buffer supplied. 
D enatu ra tion  w as for 1 m in a t 94°C, annealing  was at 57°C for 2 
min, and extension for 30 cycles w as a t  72°C for 2 min, followed by 
a final extension a t 72°C for 10 m in. Amplified DNA obtained using 
e ither rabb it or hum an  tem plate  w as cloned into the BamHI site 
of the  B luescript vector BsKs( + ) (S tra tagene). The coding sequence 
between degenerate prim ers was 45 bp long for both the rabbit and 
the  hum an  S L N  genes.
SARCOLIPIN GENE CHARACTERIZATION 543
TABLE 1
Primer Sequence Description
SALF7 5' ACAGGATCCATGGA (AG) (AC) G (ACGT) (AT) (CG) 
(ACGT) AC (ACGT) (AC) G (ACGT) GA (AG) C 3 '
(D egenerated PCR)
SALR7 5' ACAGGATCCTG (AG) TA (ACGT) (CG) (AT) (ACGT)
C (GT) (ACGT) AC (ACGT) A (AG) (ACGT) A (AG) CC 3 '
(D egenerated PCR)
SALF9 5' CTTGGATCCGTTGTCCTTATTACAGTGATCC 3' (Inverse PCR,
SALR9 5' C AAGGATC C AC AGTGAAGTTGAGAC AC AGC 3 ' rabb it SLN)
RSAF7 5' TAAGGATCCACACAGCCTGGGAGATGAGCC 3 ' (cDNA cloning,
RSAR8 5' TAAGGATC C GTGGTTGACTTAACTTTATTC AC ATG 3' rabb it SLN)
RACE1 5' CAGCCTTGACTTGAGCAGTAGCTGAGACTCAAGTCG
TGTTTTTTTTTTTTTTTTTT 3' (3 ' RACE)
RACE3 5' GTTGGATCCAGTAGCTGAGACTCAAGTCGTG 3' (3 ' RACE)
SALF10 5' CAAGGATCCGAGCTGTGTCTCAACTTCAC 3' (Inverse PCR,
SALR10 5' C AAG GATCC AGGATC ACT GTAATAAGGAC AAC 3' h u m an  SLN)
HSAF5 5' GTTGGAGCTCAAGTTGGAGACAGCGAG 3' (cDNA cloning,
HSAR5 5' GTTGAGCTC GTTGAC TTAACTTTATTC AC ATGATAG 3' h u m an  SLN)
HSAF1 5' GTTGGATC CTTGATTAC GGTTATT CTTATGTG 3' (Inverse PCR, h u m an
HSAR1 5' GAAGGATCCACAATAGTGAAGTTGAGAAACAG 3' 3 ' flanking gDNA)
HSAF8 5' GATTCTAGAGTCTTTGATCCTCTTCAGGTAACTG 3' (Inverse PCR, h u m an
HSAR8 5' TACTCTAGACTATGGCAGGTTTCTCCTCGCTG 3' 5' flanking gDNA) 
(Prim er extension)
HSAF3 5' GTCCTGGGATTGACTGAG 3' (Detection of a m inor
HSAR11 5' CCTCTGCCCTTCAGACTAG 3 ' h u m an  mRNA transcrip t)
HSAF12 5' AAA C C C AC ATC AATTG C AC 3' (5' region probe)
HSAF9 5' AGAACGGGCATTGTTATACAGG 3' (Mapping, hum an  SLN)
HPE1 5' TTTCTGAGGGCACACCAAGGACCTCTGGCTTG 3' (Prim er extension)
ta in ing  50 ng of circularized B siW l DNA w as used a s  a tem p la te  in 
an inverse PCR amplification with prim ers SALP 10 and  SA LR 10 
(Table 1). The PCR product of 1.1 kb was cleaved w ith  JSamHI, 
cloned into Bluescript, and the sequence of the 5 ' end of h u m a n  
SLN cDNA was determ ined. All eight clones analyzed s ta r te d  a t  
the A residue at position +6 of the  cDNA sequence (Figs. IB  and
2). In addition, cDNA was reamplified w ith  p rim ers H SA F5 an d  
HSAR5 from hum an  first-strand  cDNA, a n d  the sequence of the  
0.7-kb product was verified by cycle sequencing.
Determination o f the hum an S L N  gene structure , Two prim ers a t 
both ends of the full-length cDNA (HSAF5 an d  HSAR5) w ere used 
to amplify hum an genomic DNA. A single DNA product o f 4.5 kb 
with a single intron in the 5' untranslated  region of the cDNA was 
obtained. Flanking genomic DNA sequences were obtained by in­
verse PCR, in which 4 yg  of hum an genomic DNA w as cleaved w ith  
EcoRl, Bglll, o vH in à llly extracted with phenol and chlorofoiTn, pre­
cipitated with 50% isopropanol containing 250 m/l^ sodium acetate, 
washed once with 70% ethanol, and self ligated. T he inverse long 
PCR amplification used 50 ng of circularized DNA with a prim er 
pair corresponding to the 5' (HSAF8, HSAR8) or th e  3 ' (HSAF1, 
HSAR1) segments of the cDNA, respectively. For th e  3 ' end, single 
products of 5.7 and 3.5 kb were obtained from the B g lll  and  H in d ll l  
circularized genomic DNA fragments, but no product w as observed 
when 22coRI circularized DNA was used as a  tem plate. For the 5' 
region, 5-, 4-, and 0.9-kb products were obtained for B g ll ly H in d ll l ,  
and EcoRI, respectively (Fig. 1A).
Primer extension. Total RNA was isolated from norm al hum an  
skeletal muscle of two unrelated individuals as described above. The 
oligonucleotides HSAR8 or HPE1 (Table 1) were labeled w ith  poly­
nucleotide kinase and [y-32P]ATP to a specific activity of 300 nCi/ng. 
Thirty micrograms of total RNA in 30 of hybridization buffer (40 
m M  Pipes (1,4-piperazine-diethanesulfonic acid), pH 6.4, 1 m M  
EDTA, 0.4 M  NaCl, 80% formamide) was d ena tu red  for 5 m in at 
90°C and annealed overnight a t 30°C with 3 ng  of the labeled oligonu­
cleotide. The nucleic acids were ethanol precipitated, w ashed, and 
reverse transcribed as described above. The final pellet was dissolved 
in 4 (A of water, and 6 ¡A of formamide loading buffer w as added.
Cloning o f  rabbit S L N  cD NA . Knowledge of the 45-bp sequence 
of rabbit SLN cDNA lying betw een prim ers SALF7 and SALR7 (Table 
1) permitted the design of additional prim ers (SALF9, SALR9) for 
inverse long PCR amplification in which the cDNA and the whole 
pcDX vector sequence were included. PCR amplification was carried 
out with Taq  polymer as e\Pfu polymerase (5:1 ratio), using 100 ng of 
the full-length rabbit skeletal muscle cDNA library in pcDX as a 
template. An initial hot s ta r t  a t 94°C for 2 m in preceded 30 cycles 
of denaturation at 94°C for 30 s, annealing a t 62°C for 1 min, and 
elongation a t  72°C for 10 min. A single product of about 4.5 kb was 
purified on a 1% agarose gel and extracted with a gel extraction kit 
from Qiagen. About 10 ng of the  product was then b lunt ended by 
incubation with 0.7 U/fA m ung bean nuclease for 30 min a t  37°C; 
the DNA was extracted w ith  phenol and chloroform, precipitated, 
and self ligated for 12 h a t 12°C using 5 U of T4 DNA ligase in a 
volume of 200 (A. Transform ation of competent DH5a cells and selec­
tion for ampicillin resistance conferred by the coamplified pcDX vec­
tor yielded over 1000 colonies. The sequence of the full-length rabbit 
muscle cDNA was determ ined using a T7 sequencing kit (P har­
macia). To exclude any PCR cloning artifacts, rabbit SLN cDNA was 
also amplified with two oligonucleotides, RSAF7 and RSAR8 (Table
1), using the pcDX library as a template. The sequence of the 0.7- 
kb product was verified by cycle sequencing.
Cloning o f  hum an S L N  cD NA , The 3 ' end of the hum an SLN 
cDNA was cloned by application of the 3 ' RACE technique (Innis 
et aL, 1990) in which 5 ¿¿g of to ta l RNA from hum an  skeletal muscle 
was reverse transcribed w ith  p rim er RACE1 (Table 1) as described 
above. Subsequent PCR am plification with prim ers RACE3 and 
HSAF1 using  Taq polym erase :P/u polymerase (5:1 ratio) yielded 
a single product of 550 bp, w hich was cleaved with BawiHI and 
cloned into th e  Bluescript vector. Sequence analysis indicated th a t  
all eight clones analyzed w ere identical. The 5' end of hum an SLN 
cDNA was cloned by PCR am plification from a \ g t l l  5' stre tch  
cDNA library , kindly provided to us by Drs. Peter Ray and Perry  
Howard, H ospital for Sick C hildren, Toronto. Phage DNA was p re ­
pared according to the  \  phage lib ra ry  protocol from S tratagene, 
in which 1 fig of \ g t l l  DNA is cleaved by BstWI (which cuts a t 
both sides of the cDNA in se rts )  and  self ligated. An aliquot con­
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Three microliters of the  product, corresponding to 10 jug of reverse 
transcribed total RNA, was analyzed by electrophoresis on a 7.2% 
denaturing  polyacrylamide sequencing gel.
Northern blots. N orthern  blots, containing 8 fig of to tal RNA from 
rabbit fast-twitch (psoas) and  slow-twitch (soleus) skeletal muscle, 
were prepared and trea ted  as described by Ausubel et al. (1994). 
M ultiple tissue N orthern  (MTN) blots, loaded with 2 ¡ig per lane of 
poly(A)'1' RNA derived from a num ber of hum an  tissues, were pur­
chased from Clontech. A gel-purified, 0.5-kb PCR fragm ent amplified 
with prim ers HSAF1 and HSAR5 from hum an  cDNA and a 2-kb 
hum an /3-actin cDNA probe (Clontech) were labeled with [32P]dCTP 
using random  prim ers and T7 polymerase. Hybridization was carried 
out for 1 h  a t 68°C using ExpressHyb solution (Clontech) containing 
the labeled probe a t a final concentration of 5 ng/ml (1 X 108 CPM/ 
ml). The MTN blots were subjected to autoradiography for 2 ,16 , and 
72 h, a t ~70°C using Kodak /?-max film and two intensifying screens. 
The blots were stripped and  probed for /3-actin mRNA according to 
the protocol of the  m anufacturer. Autoradiography was for 4 h.
Southern blots. M ultiple species Southern (Zoo) blots, loaded 
w ith 4 ¡ug of genomic DNA cleaved with the restriction endonuclease 
-EcoRI, were purchased from Clontech and hybridized according to 
the instructions of the m anufacturer. E ither the  0,5-kb HSAF1- 
HSAR5 probe, specific for exon 2 (described above), or the 350-bp 
probe obtained with prim ers I-ISAF12 and HSAR8 , specific for the 
5 ' region of the S L N  gene, was used. The blot was washed a t low 
stringency (2X SSC, 0,05% SDS; 60°C).
Chromosomal mapping o f  the S L N  gene. To determ ine the  chro­
mosomal localization of the  S L N  gene, a  4.5-kb, PCR-amplified geno­
mic DNA fragment (HSAF5 and HSAR5) was used for fluorescence 
in situ  hybridization (FISH) experiments. FISH  was performed fol­
lowing the  procedure of L ichter et a l  (1990), by counterstain ing the 
chromosomes w ith propidium iodide and DAPI. The biotinylated 
probe was detected w ith avid in-FIT C . Im ages of m etaphase prepa­
rations were captured by a  thermo electrically cooled, charge-coupled 
cam era (Photometries, Tucson, AZ). Separate  im ages of DAPI- 
banded chromosomes (Heng and Tsui, 1993) and of FITC -targeted 
chromosomes were obtained. Hybridization signals, pseudocolored 
yellow for FITC and pseudocolored blue for D A PI-stained chromo­
somes, were overlaid electronically and m erged using Adobe Pho­
toshop 3,0 software. The band assignm ent was determ ined by m ea­
suring the  fractional chromosome length and by analyzing th e  band­
ing pa tte rn  generated by the  DAPI counter stained image.
The chromosomal localization of the  S L N  gene was confirmed by 
screening the NIGMS somatic cell hybrid panel 2 (Dubois and 
Naylor, 1993) and the GeneBridge 4 radiation  hybrid (RH) panel 
(W alter et al., 1994), purchased from Research Genetics. Radiation 
hybrid mapping experim ents were carried out in duplicate and the 
da ta  were analyzed a t a lod score of >3.0  using the  RH server from 
the W hitehead Institute/M IT Center for Genomic Research. The 
prim ers used for th is specific analysis were HSAF9 and HSAR11 
(Table 1), which amplified a 900-bp human-specific band using the 
following conditions: denaturation  a t 94DC for 30 s; annealing a t  62°C 
for 2 min; extension a t  72°C for 2 min, for 35 cycles. The complete set 
of RH data is available through the NCBI radiation hybrid m apping 
service a t http://www.ncbi,nlm,gov/SCIENCE96/.
A?ialysis o f m utations in ATP2A1 o f patients from  Brody families 
BD3 and BD6. Genomic DNA was amplified, and the 23 ATP2A1  
exons, plus 1500 bp upstream  of the transcrip tion  initiation site 
containing the  putative promoter region, were sequenced, as de­
scribed by O derm att et al. (1996). A t least 30 bp of flanking sequence 
was determined for each exon.
A nalysis o f S L N  sequence in patients o f Bj'ody families BD3 (F3) 
to BD 7 (F7). Muscle biopsies were available from Brody patients 
F4P3 and F5P3 (Table 2). F irst-strand  cDNA, prepared  as described 
above, was amplified w ith prim ers HSAF5 and HSAR5, and the se­
quence of the 0 .7-kb product was determ ined by cycle sequencing. 
Genomic DNA was isolated from blood from patien ts F3P3, F6P3, 
and  F7P3, using the Qiaamp blood k it (Qiagen). A  5-kb DNA frag­
m ent was amplified w ith prim ers HSAF12 and HSAR11. PCR ampli-
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FIG . 1. (A) S tructure  and restriction m ap of h u m an  SLN. The 
upper line shows the restriction endonuclease m ap of th e  gene de­
rived from clones obtained by PCR amplification. R estriction endonu­
clease sites are: E, EcoRI; B, Bglil; H, ifw id lll. The locations of the 
two exons w ithin the  gene (solid boxes) and th e  location of the coding 
sequence w ithin exon 2 (white box) a re  indicated on the lower line. 
The positions of the TATA and CCAAT sequences, th e  ATG initiation 
codon, and poly adénylation signal sequences are m arked, (B) Nucleo­
tide and deduced amino acid sequences of hum an  SLN . U pstream  
nucleotides, in  lowercase, are num bered negatively, on the  left, to 
the transcription in itiation site. Exon sequences are  in  uppercase and 
num bered positively thereafter. The sequence of th e  single intron is 
presented in lowercase and is not num bered. N um bers relative to 
the cDNA a t the  ends of both exons are in paren theses below the 
sequence. Putative DNA binding elem ents for eukaryotic transcrip­
tional factors are underlined and identified below th e  sequence. The 
GenBank accession num ber for these sequences are U 96092-
U96094.
fixation and cycle sequencing were perform ed as described by Oder- 
m a tt et al. (1996).
Case histories. Brody patients F3P3, F4P3, and  F5P3 were de­
scribed as patients 1 -3  in Zhang et al. (1995). P a tien t F3P3 was also 
described as patien t 1 in  K arpati et al. (1986). P a tie n t F6P3 had a  
long history of exercise- and cold-induced muscle stiffness, pain, and 
cramps. T reatm ent w ith Verapam il produced im pressive improve­
m ent in his symptoms. His m other and sister w ere  said to suffer 
from sim ilar symptoms, suggesting dom inant inheritance of the dis­
ease, No myotonia was observed e ither clinically or on electrophysio- 
logical testing. C reatine kinase was mildly elevated. Ischemic exer­
cise testing showed norm al elevation of serum  lacta te  and ammonia. 
A muscle biopsy showed nonspecific, mixed myopathic and neuro­
pathic features. P a tien t F7P3 was described as p a tien t 6 in  Benders 
et al. (1994).
RESULTS
Characterization of the Human SLN Gene
Figure 1A shows the structure and restriction map 
of human SLN, and Fig. IB provides a partial DNA 
sequence of the human SLN  gene. The partial sequence 
includes: 967 bp of the 5' region containing the proba­
ble promoter of the SLN  gene, nuceotides —967 to -1; 
exon 1 nucleotides +1 to +99, which form part of the 
5' untranslated region of the cDNA; about 300 bp of 
sequence at both the 5' and the 37 ends of the single 
3,9-kb intron; exon 2 nucleotides +100 to +719, which 
form the remainder of the 5' untranslated region, the 
coding sequence for SLN, and the 3' untranslated re­
gion of the SLN  gene; and 556 bp of downstream se­
quence. Primer extension analysis using total RNA iso­
lated from skeletal muscle of an individual with no
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agatttcctctattattcta£aaagaaaggatctgctgagcaaacacaattgcatgggtcT AT A pi
atgtttaaagtacttaattgatctgctttcaagtctaatttaacacttcaggggatccaa
a^tg^gatact^sgtta^aaactcatcttagtetaattttacLttagtgttcatattacjaE MEF3-like MEF2
B
-967
-907 
-847
-787
TATA TATA TATA
-727 tttacccagttctccttccactccc^sitctatccaaataactgagttgaactgtgtgagtCCAAT
-667 ttactgctctattaat1tattgccagaga£g^£^caaaccatgacttcctcggctgtttca
TATA
ga^gaaatgtagatcE&cgtgtaaacttgcaatgcacagcttagctggaaagttacgtggE 11 bp E
agc^ cf g£aa eg gag ggga tage 111 c ac tgc t tggacaaagtcag 11 t£gaaagagc t aa 
E MEF3-like
agatgcctattna&tt^tggagtgtgtgtgtgtgtgtatgggtgtgcatatgtgtgggtg
E c o R I  E
taaggcagcaaactcttcacatttcaaataactaaagatatgggtggtaaaatgaagtca 
catttttacaectcacagg£tga££agggagagcagtcaaatgcagcatcgattggttaaAPI E
aattagtctateat tcttggtttatgatgttttaaagacatgttaaagttattcatgaag 
atgtaaaagacaca 11: t aaaacccaca tsaa t.tg.cactaaaagtc3ac£ggaaacagaag
E 10 bp E
gtttttaaatcctggtggtggcaaattggeagccaaaggaacaaagtcttagtcaacata 
tttccatgtcccccgaacacaaatagcctcgaaccttcggagggtgttcctttgagatgt 
ttcatcagtgacatcacagtgattgccagcttccacggactaetttaggcgctgeccaga
-607
-547
-487
-427
-367
-307
-247
-187
-127
-67
+53
-7 gtccagg / AGTCCAGACAGCCTGGGAGGGGAGAAGGAGTTGGAGCTCAAGTTGGAGACAG
(+1)
CGAGGAGAAACCTGCCATAGCCAGGGTGTGTCTTTGATCCTCTTCAG/g taac t gcagga
(+99}
tttttatgcttagcatacggtgtgtgtgtgtgtacaagctgcaaatgagaaaggcagagg
aatgtttgcatttcttaatgaaataggcaatgcccttggatacagcatgccttaagatat 
aaagtgagtac tattgc tttctgttttcctttttttttctcctaagggtatgcattttct 
cccttcctagtaaaaaaaaatttttttcctttcttgtattatggaagatggtcttttttc 
tate ttctctaagtctccattcaaagaaagccaatgtcaaacttcctgcacatt tat tea
gagcttttt. . .. 3,3 kb . ...ccc
tccttaattacctaattttaacttatttacctcttaaaagaccctatcttcaaacacagt 
cacattctgagatactgtgagctagggctttgacatgtagatttttgggggacacaattt 
agcccatcacactc tcc tt ttccacaacacttctgtttcctttgaggaaagaacgggcat
tgttatacaggaatgcccattaatctccttgtgttttctttgttatgttttatcag/GAG
(+100)
GTGAGGACAAGCCAGAGGTCCTTGGTGTGCCCTCAGAAATCTGCCTGCAGTTCTCACCAA
GC CGC TGTGAAAATGGGGATAAAC ACCCGGGAGCTGTTTCTCAACTTCACTATTGTC TTG
Me t G l y l l  e A s n T h r A r g G lu L e u P h e L e u A s n P h e T h r l le V a lL e u  
ATTACGGTTATTCTTATGTGGCTCCTTGTGAGGTCCTATCAGTACTGAGAGGCCATGCCA 
I I  e T h r V a l l l  e L e u M e tT r p L e u L e u V a lA r g S e r T y r G ln T y r * *  * 
TGGTCCTGGGATTGACTGAGATGCTCCGGAGCTGCCTGCTCTATGCCCTGAGACCCCACT
tide +719 in Fig. IB. The total length of the g e n o  is 
about 5.6 kb.
A search for potential DNA binding elements fo r 
known eukaryotic transcriptional factors rev ea led  a 
cluster of three possible TATA box sequences b e tw ^ ^ n  
-745 bp and -783 bp (Fig. IB). Two additional T A T A  
boxes were found between —945 and —949 bp an d  b e ­
tween -633 and —636 bp, A CCAAT box was found  45 
bp downstream of the TATA box cluster between — *7 00 
and -704 bp. The CCAAT box of the SLN  gene, C T C -  
CCAATCT, differed from the consensus sequence GC3-Y- 
CCAATCT (Lewin, 1994) in having pyrimidines r a t t i e r  
than purines upstream of the YCCAATCT seq uen ce . 
Several E box sequences (CANNTG), recognized by  t h e
MyoD family of b asic  helix-loop—helix t r a n s c r i p t i o n a l
activators (Piette et ah, 1990; Weintraub et al., 1 9 9 0 ) ,  
were identified in the 5' region of the SLN  gene. O n e  
pair of E boxes, separated by 11 bp and lying b e tw e e n  
-587 and -609 bp, and a second pair of E boxes, s e p a ­
rated by 10 bp and lying between -198 and —219 fop, 
were located downstream of the CCAAT box. In a d d i ­
tion, a potential binding site for the myocyte e n h a n c e r  
factor MEF-2 (CTA(A/T)4TAG) was identified u p s tre s im  
of the TATA box cluster between -805 and -8 1 4  fop. 
The sequence CTTGGTTACAA, with similarity to  t h e  
MEF-3 enhancer element (TCAGGTTT(T/A)CA) d e ­
scribed by Hidaka et al. (1993), was found ju s t u p ­
stream of the MEF-2 motif between —828 and —
bp. An additional MEF-34ike motif (TCAGTTTTGAA) 
was found between —497 and —505 bp. Unlike t h e  
MEF-3 consensus sequence, the motifs found in  t h e  
gctgtcattgtcacaggatgccattctccatccgagggcacctgtgacctgcactcacaa SLN  gene had palindromic ends. We identified a p o s s i ­
ble site for the transcriptional activator protein A P -tatctgctatgctgtagtgctaggattgattatgtgttctccaaagatgctgctcccaag
GGCTGCCAAGTGTTTGCCAGGGAACGGTAG&m&TTCCCCAACTCTTAACTGAAAATGT
mRNA degradation 
GTTAGACAAGCCAC AAAG TTAAAATTAAACTGGATTCATGATGATGTAGGATTGT TACAA
putative poly (A) +
GCCCCTGATCTGTCTC AC CAC ACATCCCTTCAACCCACACGGTCTGCAACCAAAC TCTAA 
TTCAACCTGCCAGAAGGAATGTTAGAGGAAGTCTTTGTCAGCCCTTATAGCTATCATGTG 
AATAA^GTTAAGTCAACTT/Caaaaacaacttctagaacttattttagcttccatcrtcftg
poly (A)+ (+719)acagagcatttgacccttggctgggattggagtgacaagtgctaccgtatttctagcatt
tgaggtaagccaagatgctccaac tgctgaagatttgaaaccaagtcaacacactgtgtc
atatttcaagtaattccattggttcagcgctcctcaaacttttcccctaaactagtctga
aaagcapaaaaaaaataaatccattccactacggggtctgaagcacaggctgaattgctg
poly (A) ’*■gctaaaagtgcaacatttctttgaagtcttgtgttttatctttagaatccacaagaaatg 
tattttctatcttataatatc ttcatgtttgttttcatataaatatttaaaattatttac
actaagtaacacaagaacatgagtcatgtccctaagagtagcatagtctattttgattat
tgttattacacaaatggagctagtctttaatcaactacagttctaaaaggaggaaaatag
aaaatgcaaacttatatgtttataaaagacatataa
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history of genetic disease was carried out to determine 
the transcription initiation site. A single product was 
generated using primer HSAR8 (complementary to a 
sequence within exon 1; Fig. 2) or HPE1 (complemen­
tary to a sequence within exon 2; not shown). The SLN 
transcription initiation site was assigned to an A resi­
due 175 bases upstream from the translation initiation 
site in mRNA (+1 in Figs. IB and 2). The polyadenyla- 
tion site in the major transcript was located at nucleo-
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FIG. 2. Primer extension. 10 pg of total RNA from normal h u m a n  
skeletal muscle of control individuals 1 (lane 1) or 2 (lane 2 ) w e r e  
reverse transcribed using 32P-labeled oligonucleotide HSAR8. ( A ,  C, 
G, T) Sanger sequencing reactions with the same primer. The r e a c ­
tion products were resolved on a 7.2% DNA sequencing g e l,  and  
radioactivity was visualized by autoradiography. The relevant T^ TSTA 
sequence is given on the right. The transcription initiation s i t e  is 
indicated by an asterisk.
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A
Human SLN gccgtctgaaa ATG GGG ATA AAC ACC CGG GAG CTG TTT CTC AAC TTC ACT ATT GTC
M et G lv X le Asn T h r Arg Glu Leu Phe Leu Asn Phe T h r X le Val
Rabbit SLN ccacgctgaga ATG GAG QGA TCC ACC CGG GAG CTG TC3T CTC AAC TTC ACT GTT GTC
M et G lu A rg S e r T h r Arg Glu Leu Cys Leu Asn Phe T h r V a l V a l
Mouse SLN acattctgaag ATG GAG AGG TCT ACT CAG GAG CTG TTT ATC AAC TTC ACA GTT GTC
M et Glu Arg S e r T h r Gin G lu Leu Phe Xle Asn Phe T h r V a l Val
Human SLN TTG ATT ACG GTT AT3J CTT ATG TGG CTC CTT GTG AGG TCC TAT CAG TAC TGA
Leu X le T h r V a l l i e Leu M et T rp Leu Leu Val Arg S e r T y r G in T y r ** *
Rabbit. SLN CTT ATT ACA GTQ ATC CTT ATT TGG CTC CTT GTG AGG TCC TAC CAG TAC TGA
Leu l i e T h r V a l l i e Leu l i e T rp Leu Leu V al A rg S e r T y r Gin Tyr ** *
Mouse SLN CTC ATC AC£ GTT CTC CTT ATG TGG CTC CTC GTG AGG TCC TAC CAA TAC TGA
n
Leu l i e Thr Val Le ij Leu Met T rp Leu Leu V al Arg S e r T y r G in T y r * *
D
Human SLN Met G ly H e-K Asn Thr
+
Arg Glu Leu * ft •
Rabbit: SLN Met Glu
T
Arg Ser Thr
T
Arg Glu Leu » ft ft
Mouse SLN Met Glu
T
Arg Ser Thr Gin Glu Leu » « t
FIG. 3, (A) Alignment of human, rabbit, and mouse SLN  nucleotide and deduced amino acid sequences. The first 11 nucleotides, in 
lowercase, form part of the translation initiation sequence (Kozak, 1987), while the nucleotides in uppercase indicate coding sequences. 
Stop codons are italicized. Nucleotides and amino acids deviating from the consensus sequence are underlined and boldface. (B) Comparison 
of charge distribution in the hydrophilic, N-terminal domain of human, rabbit, and mouse SLN.
1 (Lee et al., 1987) between -341 and -348 bp. The 
translation initiation signal sequence (Kozak, 1987) at 
the end of the promoter sequence (GCTGTGAAA- 
ATGG) is reasonably conserved compared to the con­
sensus sequence (GCCGCCA/GCCATGG)*
Sequencing of the 3' end of the human SLN  gene 
revealed the major polyadenylation signal, AATAAA, 
between nucleotides 701 and 706, with polyadenylation 
occurring after residue 719. A potential polyadenyla­
tion signal sequence, AATAAA, was also found 252 bp 
downstream of the major polyadenylation signal se­
quence. To test whether this downstream polyadenyla- 
tional signal was used, PCR analysis was carried out 
with a forward primer (HSAF3) in exon 1 and a reverse 
primer (HSAR11) at the downstream poly(A)* site. Hu­
man skeletal muscle first-strand cDNA primed with 
oligo(dT) was used as a template. A product of 660 bp 
was amplified (not shown), indicating that the longer 
transcript was, indeed, synthesized. Contamination by 
genomic DNA was excluded on the basis of the absence 
of intronic sequence in the PCR product. We estimate 
that the level of the longer transcript was less than 5% 
of that of the major 719-bp transcript. There was no 
indication of the use of a potential polyadenylation sig­
nal sequence, AATTAA, 158 bp upstream of the major 
signal sequence.
Isolation and Analysis of cDNA Clones Encoding
Rabbit and Human SLN
Nucleotide sequence. Figure 3 illustrates the nucle­
otide sequences encoding human, rabbit, and mouse 
SLN and their deduced amino acid sequences. The rab­
bit sequences were confirmed in eight clones obtained 
from a cDNA library by circularization, following in­
verse long PCR amplification from primers in exon 2.
The human sequences were obtained by similar meth­
ods, as outlined under Materials and Methods. Se­
quences from mouse cardiac and skeletal muscle SLN 
were obtained from a computer search of the GenBank 
EST database, which also identified human SLN EST 
sequences (Washington University School of Medicine- 
Merck EST project) covering most of the full-length 
cDNA, but lacking the 5' and 3 ' tails.
Comparison of human, rabbit, and mouse SLN 
cDNAs revealed 84% nucleotide sequence identity be­
tween human and rabbit, 44% nucleotide sequence 
identity between human and mouse, and 41% nucleo­
tide sequence identity between mouse and rabbit SLN 
cDNAs. The higher level of nucleotide sequence iden­
tity between the human and rabbit SLN cDNAs is re­
flected in their identical length and in their use of the 
same polyadenylation signal sequence for the major 
transcript, 14 bp upstream of the poly(A)+ tail. This 
polyadenylation site is lacking in the mouse SLN ESTs, 
which contain a consensus polyadenylation signal se­
quence 150 bp further downstream, with polyadenyla­
tion occurring an additional 100 bp downstream. The 
length of the mouse SLN cDNA is at least 950 bp. An 
AUUTJA motif that could act as an RNA degradation 
signal (Shaw and Kamen, 1986) is present in the major 
transcript of human and rabbit mRNA, about 250 bp 
downstream of the stop codon, but is lacking in the 
mouse transcript. Another potential polyadenylation 
signal sequence, present in all three species, is located 
50 bp downstream of the potential RNA degradation 
signal. The first 11 nucleotides, which include the 
translation initiation signal sequence (Kozak, 1987), 
are not well conserved among the three species.
Amino acid sequence. The SL N  gene encodes a pro­
tein of 31 amino acids that can be divided into three
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Human PLN
•  ♦ •  •
•  •
MGINTRELFLNFTIVLITVILMWLLVRSYQY Human SLN 
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FIG. 4. Alignment of human SLN and PLN peptide sequences. 
Amino acids 23 to 52 of human PLN are shown in the upper line. 
The lysine at position 27 of human PLN is replaced by an asparagine 
in PLN of rabbit, dog, and pig (above). The peptide sequence of hu­
man SLN is shown in the lower line. Amino acids different in rabbit 
or mouse are indicated beneath. The vertical lines in the alignment 
indicate identical amino acids, whereas conserved amino acids are 
shown by two vertical dots. The asterisk indicates the first and last 
amino acid of the predicted transmembrane helix of SLN.
domains: a hydrophilic N -term inal domain of 7 amino 
acids; a hydrophobic, transm em brane helical domain 
of 19 amino acids; an d  a hydrophilic C-terminal domain 
consisting of 5 amino acids. N either the hydrophilic N- 
terminal sequences nor the  hydrophobic transmem- 
brane sequences are  well conserved among the three 
species studied, and changes in ne t charge occur in 
the N-terminal sequences. The hydrophilic C-terminal 
sequences are, however, perfectly conserved. The 
amino acid sequence of the  rabbit protein, deduced 
from the cDNA, is identical to the  peptide sequence 
determined by Wawrzynow et al. (1992).
The SLN sequence from residue 4 to residue 26 (4 
N-terminal hydrophilic residues and 19 hydrophobic 
transm em brane residues) shares a striking similarity 
with residues 28 to 49 of PLN (Fig. 4). This similarity 
becomes more evident if a lternate  residues at different 
points in the sequences of the  th ree  species are consid­
ered, Asn4 in hum an SLN corresponds to Asn27 in PLN 
in  rabbit, pig, and dog. Gin6 in mouse SLN corresponds 
to Gin29 in hum an PLN. At hum an SLN positions 10, 
20, and 22 Leu, lie, and  M et differ from the correspond­
ing residue in hum an PLN, bu t in other species, corre­
spondence of one or more of these residues is observed. 
On the basis of these sequence similarities, we propose 
tha t SLN and PLN a re  homologous proteins. Since the 
orientation of PLN in  the  m em brane is well estab­
lished, we propose th a t  the  N-terminal domain of SLN 
is cytosolic and th a t  the  C-terminal domain faces the 
lumen of the sarcoplasmic reticulum.
Characterization of S L N  Expi'ession
SLN transcript was found in rabbit fast-twitch skeletal 
muscle (psoas) than  in slow-twitch skeletal muscle (so- 
leus) (Fig. 5C).
Multiple-Species Genomic DNA Analysis
A Southern blot containing genomic DNA from nine 
eukaryotic species, digested with restriction endonucle­
ase EcoRl, was probed with a 350-bp, PCR-amplified 
DNA fragment from the 5' exon 1-containing region of 
the SL N  gene (Fig. 6). A single band was detected in 
genomic DNA from each of hum an (0.9 kb), monkey 
(0.95 kb), dog (1.5 kb), cow (1.05 kb), and rabbit (4.4 
kb). The size of 0.9 kb of the i?coRI-digested hum an 
genomic DNA fragment confirmed the finding of a 0.9- 
kb DNA product obtained by inverse PCR amplification 
with primers specific for the 5' region of th e  SL N  gene. 
Genomic DNA from chicken yielded two bands of 1.6 
and 2.6 kb. The hybridization signal of the hum an 
probe with mouse and ra t  genomic DNA was very weak, 
reflecting the fact th a t there is much lower similarity 
between hum an and mouse SLN cDNAs th an  between 
hum an and rabbit SLN cDNAs. No hybridization to 
digested yeast genomic DNA was observed. A similar 
pa tte rn  was obtained using a labeled probe specific for 
the 3 ' region of the S L N  gene (not shown).
Chromosomal Localization
To determine the location of the SLN  gene, we per­
formed FISH using a 4.5-kb, PCR-amplified DNA probe 
covering both exons and the single intron. Positive sig­
nals were observed on both chromosome 11 chromatids 
in the region of I lq 2 2 -q 2 3 . No hybridization to any 
other chromosome was observed. The assignm ent of 
the SL N  gene to hum an chromosome 11 was confirmed 
using monochromosomal rod en t-h u m an  somatic cell 
hybrids. To refine the position of the gene on the genetic 
and physical map of l lq ,  we screened the GeneBridge 
4 RH panel. The results indicate th a t  S L N  is flanked 
by the two genetic m arkers CHLC.GATAGCll and 
CHLC.GATA71E06. S L N  was 7.04 cR from the former 
marker. Although this entire region appears to be cov­
ered by a set of overlapping YACs (Hudson et al., 1995), 
our analysis failed to detect a positive clone for the 
S L N  gene from this collection. Nevertheless, the FISH 
and RH data are consistent, indicating th a t  the gene
The distribution of S L N  mRNA in various hum an  maps to hum an chromosome I lq 2 2 -q 2 3 .
tissues was determ ined by N orthern  blot analysis us­
ing a PCR-amplified probe from the 3 ' un transla ted  
region of the cDNA th a t  hybridized to a single tra n ­
script of 0.7 kb (Fig. 5). This SL N  transcrip t was highly 
expressed in skeletal muscle, bu t was a t least 50-fold
Sequencing of SLN  from Patients o f  Brody Families 
BD3 to BD7
No mutations were found in the sequence of the SLN
less abundant in h e a r t  muscle, as determined by densi- cDNA amplified from patients F4P3 (recessive inheri-
tometry of the exposed film. Only trace amounts were 
detected in prostate and pancreas. In all other tissues 
analyzed (brain, placenta, lung, liver, kidney, u terus, 
colon, small intestine, bladder, and  stomach), no S L N
tance, Table 2) or F5P3 (dominant inheritance), nor were 
any mutations found in the sequence of the SLN  gene 
amplified from genomic DNA from patients from families 
BD3 (recessive), BD6 (dominant), or BD7 (dominant) (Ta-
transcript was detected. A 9-fold higher level of the ble 2). Genomic sequences included each of the two exons
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FIG* 5. Analysis of SLN  gene expression. Human multiple tissue Northern (MTN) blots (Clontech) containing: (A) mRNA from heart, 
brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas; and; (B) skeletal muscle, uterus (no endometrium), colon (no mucosa), 
small intestine, bladder, heart, stomach and prostate (top) were probed with a 0.5-kb PCR product (HSAF1-HSAR5) derived from human 
SLN cDNA. The positions of RNA size markers (kb) are indicated on the left. Autoradiography was earned out for 16 h at —70°C. (Bottom) 
The same blots were probed with a human /?-actin cDNA and exposed for 4 h. The second hybridization signal at 1,6-1.8 kb observed in 
both heart and skeletal muscle is due to probe hybridization to either the a or the 7 form of actin (Giovanna et ah, 1991; Lamballe et al., 
1991). (C) Analysis of SLN  expression in rabbit fast-twitch and slow-twitch skeletal muscle. The Northern blot was probed with the 0.7- 
kb RSAF7-RSAR8 PCR product, specific for rabbit SLN mRNA, Autoradiography was for 6 h.
and a t  least 100 bp of intron sequence flanking each exon 
and 850 bp of the proposed promoter region. The substitu­
tion of G for C l l  in the 5' untranslated region of exon 2 
was detected in patient F3P3. The insertion of a T in 
both alleles at position —118 was observed in patient 
F6P3. This mutation did not affect the structure of SLN 
and was not considered significant.
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FIG. 6. Southern blot analysis of the SLN  gene. A multiple spe­
cies Southern blot (Clontech) was probed with the 350 bp HSAF12-  
HSAR8 PCR product, specific for the 5' region of the human SLN  
gene, and washed under low-stringency conditions (60°C: 2x SSC,
0,05% SDS). Positions of DNA size markers are indicated on the left.
Sequencing o fA T P 2A l from Genomic DNA of 
Patients F3P3 and FGP3
Sequence analysis of ATP2A1 from genomic DNA of 
patien t F6P3 (dominant) did not reveal any mutations 
in the putative promoter region, in  the two exons, or 
in 10-100 bp of intronic sequence flanking each exon. 
The substitution of T for C678, a polymorphism that 
does not change the amino acid sequence (Zhang et a l ,  
1995), was detected in  patient F6P3.
The fact that no detectable defect in either SLN  or ATP- 
2A1 (Zhang et a l ,  1995) had been found in patient F3P3 
(recessive), who had been reported to be devoid of SERGA1 
(Karpati et al, 1986), led us to a reexamination of ATP2A1 
in this patient and his brother (patient 2 in Karpati et al, 
1986). Haplotyping of the region surrounding ATP2A1 as 
described by Odermatt et a l  (1996) showed that these 
brothers had the identical haplotype on both chromo­
somes, indicating homozygosity in this region (not shown). 
The fact that the parents in this family were first cousins 
is consistent with this degree of homozygosity.
Resequencing of ATP2A1 from patien t F3P3 showed 
the presence of the T for C678 polymorphism noted 
earlier (Zhang et al. ,  1995), bu t th is  time the  deletion 
of a C in a series of three Cs (cDNA nucleotides 437 
to 439) was detected (Fig. 7). This deletion led to a 
homozygous frame shift a t P ro147, which would lead to 
a stop codon in  both transcrip ts after the incorporation
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Family
BD1 
BD2
BD3
BD4
BD5
BD6
BD7
TABLE 2
Analysis for Mutations in ATP2A1 and SLN of Brody Families
Patient
F1P3, F1P4 
(F2P1),C F2P3, F2P4 
(F2P2),B F2P3, F2P4
F3P3, F3P4
F4P3
F5P3
F6P3
F7P3
0 Odermatt et a l  (1996). 
b Benders et al. (1994). 
c Unaffected father. 
d Karpati et al. (1986). 
e Unaffected.
f Zhang et al (1995).
ATP2A1
Homozygous Arg198 to Stop 
CysG7r> to Stop, and intro n 
3 splice donor GT to CT 
(compound heterozygote 
Homozygous deletion of a C 
frameshift at Pro147 
No mutation 
No mutation 
No mutation 
n. d.
SLN
n. d. 
n. d.
No mutation
No mutation 
No mutation 
No mutation 
No mutation
Inheritance
Recessive
Recessive
Recessive
Recessive
Dominant
Dominant
Dominant
Reference
FlP3,° P4ft 
F2P3,“ P3rf
PUd P i '
P2/'
P3r
P66
of 33 additional amino acids. This mutation is very 
similar to the two cases of ATP2A1 -linked Brody dis­
ease described earlier (Odermatt et al.} 1996) in tha t 
mutations in both alleles led to premature termination 
codons and to truncation of SERCAl, In three of four 
cases of autosomal recessive inheritance of Brody dis­
ease described to date, SERCAl protein has been lost 
due to these truncations (Table 2). Our results suggest 
that mutations in ATP2A1, leading to a predicted func­
tional knock-out of SERCAl, account for the majority 
of autosomal recessive forms of Brody disease, but not 
for dominant forms of the disease.
DISCUSSION
Cloning of Rabbit and Human SLN  by Application 
of Inverse Long PCR  Several earlier attempts in our
to clone S L N  by hybridization screening of a
were unsuccessful, even though
the cDNA is present in our pcDX library, as described 
here, and is present in other libraries from both skele­
tal and cardiac muscle (Washington School of Medi- 
cine-Merck EST project, GenBank). In  this study, we 
cloned the SLN  gene from our full-length rabbit skele­
tal muscle cDNA library in the pcDX vector by a novel 
application of inverse long PCR. In this method, the 
vector sequence, containing an antibiotic resistance 
marker, was coamplified with the full-length cDNA, 
allowing us to self-ligate the PCR product and use the 
circularized DNA directly for transformation of compe­
tent bacterial cells. Since self-ligation was very effi­
cient, as little as 1 ng of circularized PCR product was 
sufficient for successful cloning. By inverse long PCR, 
products up to 8 kb in length have been obtained. Ac­
cordingly, this method has potential application for di­
rect cloning of even very long cDNAs inserted  into vec­
tors of the usual length of about 4 kb. For example, we 
have successfully cloned full-length ATP2A1 cDNAs of
BD3
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3.5 kb from our pcDX library. The use of Pfu polymer­
ase to avoid PCR artifacts is strongly recommended.
We also applied inverse long PCR to a human skele­
tal muscle 5' stretch cDNA library in \g t l l  to clone 
human SLN. The phage DNA was digested with an 
enzyme flanking the cDNA at both sides, and the circu­
larized DNA was used as a template for inverse long 
PCR. The disadvantage of using phage library tem­
plates is the lack of a selectable marker on the ampli­
fied product. Accordingly, it is necessary to recover 
much higher yields of the PCR product for cloning into 
a plasmid vector.
5' Upstream Region of the Human SLN gene
In the SLN  gene, a cluster of three TATA box ele­
ments is located about 40 bp upstream of a CCAAT 
box, which, in turn, is found 700 bp upstream of our 
proposed transcriptional start site. A similar unusual 
arrangement of CCAAT and TATA box elements was 
described for the skeletal muscle RYR1 gene (Phillips 
et ah, 1996), with a CCAAT sequence 68 bp upstream 
of the transcription initiation site and a cluster of five 
TATA box elements a further 1500 bp upstream. A 
binding site for the myocyte enhancer factor, MEF2, in 
combination with a MEF3-like element, follows just 
upstream of the TATA box cluster in the SLN  gene. 
The muscle-specific induction of the aldolase A gene 
has been shown to be controlled through cooperation 
between the muscle-specific factor MEF2 and the more 
ubiquitous factor MEF3 (Hidaka et aL, 1993). An addi- 
tonal MEF3-like site is located 200 bp downstream of 
the CCAAT box in the SLN  gene. The 5' region of the 
SLN  gene contains several E boxes (CANNTG). E 
boxes, which are recognized by the MyoD family of ba­
sic -helix-loop-helix transcriptional activators, occur 
by chance every 250 bp in DNA sequences. However, 
MyoD has been shown to bind cooperatively to paired 
sites with a 19-bp space in the muscle creatine kinase 
enhancer (Weintraub et aL, 1990) and to paired sites 
with a 12-bp space in the acetylcholine receptor a-sub- 
unit enhancer (Piette et aL, 1990). In the SLN  gene, 
two E box pairs with 11 and 10 bp space between both 
E boxes follow about 200 and 500 bp downstream of 
the CCAAT box. These DNA binding elements might 
be responsible for the muscle-specific expression of the 
SLN  gene revealed by Northern analysis. In contrast 
to the ATP2A1 gene (Korczak et aL, 1988) and the 
RYR1 gene (Phillips et aL, 1996), Spl sites and the 
proposed muscle-specific promoter element GGC- 
TGGGG are absent from the SLN  promoter region.
Conservation of SLN in Different Species
Alignment of amino acid sequences of SLN from hu­
man, rabbit, and mouse (this study; Washington School 
of Medicine-Merck EST project, GenBank; Wawrzy- 
now et aL, 1992) revealed poor conservation of the hy­
drophilic N-terminal sequence, a relatively well-con­
served hydrophobic transmembrane sequence, and per­
fect conservation of the C-terminal hydrophilic 
sequence, which, by analogy with the well-character­
ized structure of phospholamban (Fujii et aL, 1991), 
should lie in the lumen of the sarcoplasmic reticulum. 
The functional consequences of the different charge dis­
tribution in the cytoplasmic domain of SLN in the three 
species are not clear. By contrast, SERCA1, with which 
SLN seems to interact, is highly conserved between 
rabbit and human (Zhang et aL, 1995). The low level 
of conservation of the SLN cDNA between different 
species is also reflected in the weak hybridization sig­
nal obtained on a Zoo blot using a human SLN  probe. 
One or two main bands were detected in all species 
tested, except yeast (Fig. 6).
Relationship between SLN and PLN Genes
The human SLN  and PLN  (Fujii et aL, 1991) genes 
share common features, consistent with their origin in 
a common ancestor. Both genes contain two exons and 
one intron. In both cases, the intron is located about 
90 bp downstream of the transcription initiation site, 
and in both cases it interrupts the 5' untranslated se­
quence, so that the entire coding sequence is located in 
exon 2. The introns are relatively large, about 3.9 kb 
long in SLN  and about 6 kb long in PLN. The 3' ends 
of both genes contain multiple polyadenylation signals, 
and more than one polyadenylation site is used in both 
genes (Fujii et aL, 1988). Alignment of human SLN 
and PLN cDNA reveals 60% nucleotide identity in the 
region encoding the predicted transmembrane helices, 
even though only 30% identity is observed for the N- 
terminal and C-terminal domains (not shown).
On the basis of the conservation of amino acids in 
parts of the N-termini and much of the transmembrane 
helices of SLN and PLN, we propose that SLN and 
PLN are homologous proteins. It is possible that they 
have achieved this degree of sequence identity by con­
vergent evolution, but, in light of the similarity in gene 
structure, it seems much more likely that sequence 
similarity is based on divergent evolution from a com­
mon gene.
The differences in the N- and C-terminal sequences 
of SLN and PLN must reflect their different interac­
tions with different cytoplasmic proteins (PLN is phos- 
phorylated by protein kinase A, but SLN is not), but 
their conserved transmembrane sequences suggest re­
tention of the ability to interact with conserved trans­
membrane sequences in other proteins. The three 
SERCA molecules (Burk et aL, 1989) are the most likely 
candidates for such interactions. PLN is coexpressed 
with SERCA2a and interacts functionally with it. PLN 
also retains the capacity to inhibit SERCA1 (Toyofuku 
et aL, 1993), but does not do so because the two proteins 
are not coexpressed in the same tissue. SLN is most 
highly expressed in fast-twitch muscle, where SERCAl 
is highly expressed and the two proteins copurify (Mac-
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Lennan et aL, 1972). In our most recent in vitro coex­
pression experiments, we have found that SLN inhibits 
SERCAl by decreasing its apparent affinity for Ca2+ 
(A. Odermatt, S. Becker, V. K. Khanna, K. Kurzydlow- 
ski, and D. H. MacLennan, unpublished). Since PLN 
inhibits the activity of SERCA2a by decreasing its ap­
parent affinity for Ca2+, SLN may act as the counter­
part of PLN in fast-twitch skeletal muscle.
Transmembrane helices M4, M5, and M6, which are 
key to Ca2* binding and translocation in SERCAl (Rice 
and MacLennan, 1996), are highly conserved in all 
three SERCA molecules. Thus the three transmem­
brane sequences in SERCA molecules and the single 
transmembrane sequence in SLN/PLN molecules may 
have coevolved, conferring a degree of evolutionary sta­
bility on each other, The cytoplasmic domain of PLN 
also interacts with a cytoplasmic domain of SERCA2a 
(Toyofuku et aL, 1994). This site is conserved in SER­
CAl, but is missing from SERCA3.
The SLN  gene is expressed most abundantly in fast- 
twitch skeletal muscle (Fig. 5C), the tissue in which 
SERCAl is expressed almost exclusively, This is also 
the tissue from which SLN was first isolated, in associ­
ation with highly purified SERCAl (MacLennan et aL, 
1972), Like SERCAl expression (Wu and Lytton, 1993), 
SLN expression is 10 times lower in slow-twitch skele­
tal muscle (soleus) than in fast-twitch skeletal muscle 
(WST, EDL). In cardiac tissue, the concentration of the 
SLN transcript is about 50-fold less abundant than it is 
in skeletal muscle (Fig. 5A). SLN  expression is another 
order of magnitude lower in pancreas and prostate (Fig. 
5B), where SERCA2b predominates. PLN is expressed 
most abundantly in cardiac and slow-twitch skeletal 
muscle, where SERCA2a is the predominant SERCA 
molecule, and at much lower levels in fast-twitch skele­
tal muscle and smooth muscle (Fujii et aL, 1988). Thus 
SLN and PLN are expressed in muscle-specific and 
complementary patterns, and the patterns of their ex­
pression are directly correlated with the expression of 
different SERCA molecules in each muscle tissue. On 
the basis of data presented in this paper, we propose 
that SLN  and PLN  be recognized as two members of a 
gene family.
A Potential Role for SL N  in Brody Disease
Kimura et aL (1996) demonstrated that the pre­
dicted PLN transmembrane a-helix is the inhibitory 
domain of the PLN molecule. More recently, Kimura 
et aL (1997) described mutations in the predicted 
PLN transmembrane a:-helix that resulted in a dra­
matic gain of PLN inhibitory function, manifested as 
a lowering of the apparent affinity of SERCA2a for 
Ca2'\ They proposed tha t mutations in PLN or SER- 
CA2a that decreased the apparent affinity of SER- 
CA2a for Ca24' under physiological conditions could
lead to cardiomyopathy.
Because a mutant SLN, like a mutant PLN, might
gain inhibitory function leading to the morbidity a s s o ­
ciated with a highly inhibited form of SERCAl, w e  i n i ­
tiated a search for SLN mutants in the four Brody f a m i ­
lies with non-ATPMi-linked Brody disease and w i t h  
a fifth family available to us. Unfortunately, w e  d i d  
not find any alterations that would support S L N  a s  a  
candidate gene for Brody disease in these five fam ilie s*  
In additional studies of BD, we showed th a t  tw o  
brothers in family BD3, in which ATP2A1 m u ta t io n s  
had not been found in an earlier study (Zhang aZ,,
1995), shared a common haplotype on chrom osom e
16pl2.1-pl2.2, suggesting the need for réévaluation  o f
the role of the ATP2A1 gene in the disease. This l e d  u s  
to resequence ATP2A1 in this family and to the d i s c o v ­
ery of a fourth BD mutation that would t r u n c a t e  
SERCAl. Currently four mutations in three BD f a m i ­
lies are known, all resulting in recessive inheritance  o f  
BD. The only recessive BD family that has not b e e n  
shown to have an ATP2A1 mutation is BD4 (T ab le  2 ) . 
We are currently haplotyping two brothers in th is  f a m ­
ily to determine whether resequencing of A T P 2 Æ 1  
might be warranted. In three other BD families w h e ir e  
inheritance is dominant (Table 2), the causal g e n e  h a s  
yet to be discovered.
SLN  localizes to human chromosome llq22—q 2 3 ,  a  
region frequently deleted in several hematological m a ­
lignancies. In acute leukemias, the MLL (ALL1, 
and HTRX) gene, which maps to llq23, is involved i n  
reciprocal translocations with a large number o f  g e n e  
partners (Bernard and Berger, 1995). Leukemias m a n i ­
festing llq23 rearrangements have been shown to  b e  
associated with very poor prognosis (Rasio et aL, 1 9 9 6 )  ■ 
This region also seems to be sensitive to DNA to p o is o m -  
erase II inhibitors, as the majority of th e ra p y -re la te d  
leukemias resulting from treatment with these i n h i b i ­
tors demonstrate MLL rearrangements (Canaani e t  c t l^  
1995). Cultured cells harboring such deletions m i g h t  
provide an interesting experimental system for t h e  i n ­
vestigation of the function of SLN in cell physiology -
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